Myrexis, Inc. (MYRX) Posts Narrower than Expected Q4 loss
Tweet
Share
E-mailGet Alerts MYRX Hot Sheet
Join SI Premium – FREE
Myrexis, Inc. (NASDAQ: MYRX) reported Q4 EPS of ($0.31), $0.04 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $185 thousand versus the consensus estimate of $90 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kenon Holdings (KEN) halted, news pending
- Valens Semiconductor (VLN) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
